Companies / Crosslink Therapeutics
Crosslink Therapeutics
United States
Crosslink Therapeutics is developing biologics for the treatment of cancer
Crosslink Therapeutics, based in United States, has 1 investor on file, among them Cure Ventures. Its latest round on record is Series A, 20 Oct 2026. Its site was last checked 6 Nov 2026: site answers.
Funding
1 round on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from Cure Ventures
10 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Crosslink Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Cure Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/xlinktx.com/investors
# also
GET /v1/companies/xlinktx.com
GET /v1/companies/xlinktx.com/news